TY  - GEN
AU  - Michalaki,Vasiliki
AU  - Fotiou,Stylianos
AU  - Gennatas,Spyridon
AU  - Gennatas,Constantine
TI  - Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results
SN  - 1791-7530
PY  - 2010///0830
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Capecitabine
KW  - Deoxycytidine
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Prospective Studies
KW  - Receptor, ErbB-2
KW  - biosynthesis
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
KW  - Taxoids
KW  - Trastuzumab
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
ER  -